Description

SOSUM M is a medium-density cross-linked hyaluronic acid dermal filler developed for professional correction of moderately pronounced facial lines and folds. It contains 20 mg/ml hyaluronic acid and is normally supplied as two 1 ml prefilled syringes.

The “M” formulation occupies the middle position in the SOSUM range. Its gel profile is firmer than SOSUM S but less structurally dense than SOSUM H. Product selection and administration must only be undertaken by an appropriately qualified healthcare professional.

What is SOSUM M?

SOSUM M is a South Korean professional dermal filler manufactured with cross-linked hyaluronic acid. The formulation is commercially positioned for moderate facial lines, folds and applications requiring a balance between flexibility and physical support.

Each standard box contains two individual 1 ml syringes, providing a total product volume of 2 ml. The standard CE-marked presentation is commonly supplied without lidocaine, although customers must verify the ingredient panel on their particular box.

SOSUM M is an injectable professional product. It is not a topical cosmetic, a skin booster or a product suitable for self-administration.

SOSUM M product specifications

• Product name: SOSUM M
• Product type: Cross-linked hyaluronic acid dermal filler
• Hyaluronic acid concentration: 20 mg/ml
• Individual syringe volume: 1 ml
• Pack size: Two prefilled syringes
• Total product volume: 2 ml
• Gel profile: Medium-density formulation
• Published particle size: Average greater than 500 μm
• Lidocaine: Standard CE presentation is commonly supplied without lidocaine
• Manufacturer: JSBIO Co., Ltd.
• Country of origin: South Korea
• Published storage range: 2–25°C
• Published shelf life: Two years
• Intended user: Appropriately qualified healthcare professionals

Key characteristics of SOSUM M

SOSUM M uses cross-linked hyaluronic acid with a medium gel profile. This formulation is intended to provide more structural support than the smaller-particle SOSUM S while retaining greater flexibility than the firmer SOSUM H formulation.

The gel is produced using a low-temperature cross-linking process. Published product information describes a two-stage purification process intended to minimise residual cross-linking material. These manufacturing descriptions must not be treated as a guarantee that complications or reactions cannot occur.

Professionals should base product selection on the patient’s anatomy, tissue characteristics, medical history and treatment objectives. The product name or website description alone cannot determine suitability.

Cross-linked hyaluronic acid

Hyaluronic acid is a naturally occurring substance found within human tissue. In professional dermal fillers, cross-linking creates a structured gel intended to provide temporary physical volume and support.

SOSUM M contains 20 mg/ml cross-linked hyaluronic acid. It is distinct from non-cross-linked skin boosters, which are formulated and used for different purposes.

Results and duration vary according to the treatment area, volume administered, professional technique and individual metabolism. No fixed outcome or exact duration should be promised.

SOSUM M compared with S and H

The standard SOSUM range offers three gel profiles for different professional requirements:

• SOSUM S: Soft, small-particle formulation commercially positioned for fine and superficial correction.
• SOSUM M: Medium-density formulation for moderately pronounced lines, folds and balanced support.
• SOSUM H: Firmer, larger-particle formulation for applications requiring greater structural support.

The letters identify different gel formulations rather than package sizes. The appropriate version should only be selected following a professional assessment.

Professional consultation and suitability

SOSUM M must only be administered by a healthcare professional with suitable qualifications, training, insurance and legal authority. It must not be self-injected, used at home or administered by an untrained person.

A consultation should review relevant medical conditions, current medication, allergies, previous filler procedures, existing implants, skin condition and treatment expectations. The professional should identify any contraindication or reason to postpone treatment.

Potential risks, complications, alternatives and aftercare should be explained before proceeding. Patients should also be told how to obtain professional help if they experience unexpected or concerning symptoms.

Packaging and authenticity checks

Inspect every SOSUM M box before professional use. Confirm the complete product name, two-syringe pack size, 20 mg/ml concentration, batch number, expiry date and condition of the sterile packaging.

Do not use the product if the packaging or syringe is damaged, leaking, open or altered. Products that cannot be authenticated or whose storage history cannot be established should not be administered.

Retain the invoice, box and batch details to support traceability. Check the label for lidocaine and ensure that the online listing matches the formulation you are supplying.

Storage and responsible handling

Published product information recommends storing SOSUM M in a cool place away from direct sunlight, commonly between 2°C and 25°C. Always follow the instructions printed on the supplied packaging.

Keep each syringe sealed until required. The syringes are intended for single-patient professional use and should be disposed of according to relevant infection-control, sharps and clinical-waste requirements.

Important regulatory information

This description provides general commercial information. It is not medical advice, an injection protocol or confirmation that SOSUM M is authorised for every application or country.

Purchasers are responsible for establishing whether the product can legally be imported, supplied and used for their intended purpose. Practitioners must follow the instructions supplied with the specific product.

For additional specifications, review the SOSUM M product information. You can also browse professional products available from The Clinic Vault shop.

Order SOSUM M

Each standard box contains two 1 ml prefilled syringes, providing a total volume of 2 ml. Before ordering, confirm that the medium-density M formulation and non-lidocaine presentation match your requirements.

Add SOSUM M to your basket when ready, or contact The Clinic Vault for clarification about packaging or availability. This product is intended for qualified healthcare professionals and must not be self-administered.